Boston Scientific said Wednesday is forecasting a $25 million hit to its 2019 revenue after the U.S. Food & Drug Administration yanked two of its product lines from the market.
Westborough biotech Miach Orthopaedics has added two senior executives with expertise in regulatory submissions and clinical trials as the company looks to bring its ACL repair technology to market.
ReWalk Robotics saw its stock skyrocket Tuesday as the company said it has sold its first personal exoskeleton device to a spinal cord injury patient via insurance firm Cigna Corp.
The U.S. Food and Drug Administration has ordered Marlborough medical device maker Boston Scientific and another manufacturer to immediately stop selling transvaginal surgical mesh products.
Ceramics manufacturer PremaTech Advanced Ceramics is hoping Worcester will help facilitate its planned $4.1-million expansion at its Goddard Memorial Drive facility with a 10-year tax deal.
A week after starting talks with Leicester, marijuana retailer Cultivate has begun negotiations with Uxbridge for a cannabis cultivation and manufacturing facility of up to 130,000 square feet.